At the news
? NEUTRALIMPACT 3/10 CLUSTER filed Jul 2, 2026 at 18:02 ET
Nurix Therapeutics chief legal and scientific officers sold $688K in stock, including a single-day CLO sale of $581K. The cluster is small relative to the $2.5B market cap (0.03%) and fits a common vesting/exercise pattern, the legal officer exercised 22,016 derivative shares at $0-$8.72 alongside her sales. The dollar value is well below materiality thresholds and the sales pattern is consistent with tax-planning liquidity, not informed bearish conviction.
- Two C-suite insiders sold a total of ~34,300 shares across two dates
- Total open-market sale value is $688K, or ~0.03% of $2.5B market cap
- CLO exercised 22,016 derivative shares for $60K (mostly non-cash), then sold a portion
- CSO sold 5,400 shares for $108K on June 25
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access